Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Timing rebalance decisions for SP 500 retirement funds helps keep your portfolio aligned with goals. This intro covers practical triggers.
16,462 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Silver prices have surged, lifting miners' profits and spurring a new wave of income-focused ETFs. Three TSX-listed f...
Oregon's push to shift recycling costs to manufacturers promised cleaner streets and better recycling, but the rollou...
When a major holding shows a sharp fall after earnings, investors scramble for answers. This guide breaks down the re...
Long-dated Treasuries surged as Memorial Day markets opened, pushing debt service higher and sharpening questions abo...
Vistra's Q1 2026 results shed light on margin dynamics across generation, retail, and renewables. This guide breaks d...
SpaceX could redefine aerospace and energy, but investing in Elon Musk-backed ventures is no simple bet. This guide u...
A 62-year-old retiree faces the challenge of sustaining $65,000 in annual spending with investment income. This piece...
The US is accelerating domestic rare-earth initiatives, and investment banks keep raising targets on MP Materials. Th...
Public blunders can impact more than pride—they can touch endorsements, streaming dollars, and future opportunities. ...
Unlock Technologies announced the closing of a $358.5 million home equity agreement securitization, the largest HEA d...
As Chewy released its latest earnings, investors faced mixed signals: growing revenue and better margins, but cautiou...